Excellence Through Research and Development of Innovative Biotechnology
HA TECH is an Australian based Company, Developing & Delivering innovative Diagnostic and Pharmaceuticals products, focuses on the diagnosis of serious infectious diseases: respiratory Including COVID-19, sexually transmitted infection (STI) and mosquito-borne diseases that affect hundreds of millions of people worldwide and are among the most urgent global health challenges. The Company is making long-term investments to develop pharmaceutical products and medical technologies/ devices to address major health problem in Australia and globally.
Latest News
As members of the global healthcare community, HA TECH focuses on reducing the burden of disease with our products and development of novel technologies.
12
Apr
HA TECH Monkeypox Virus Real-Time PCR Diagnostic Kit receives TGA Approval, launches in Australia
Sydney, NSW (12 April 2023) – The HA TECH Monkeypox Virus Real-Time PCR Diagnostic Kit launches in Australia. The kit is the first comm...
28
Mar
HA TECH SARS-CoV-2 & Influenza A/B Rapid Antigen Test Kit receives TGA Approval, launches in Australia
Sydney, NSW (28 March 2023) – The HA TECH SARS-CoV-2 & Influenza A/B Combo Rapid Antigen Test Kit launches in Australia. The kit ha...
17
Nov
HA TECH SARS-Cov-2 Rapid Antigen Test Kit Receives TGA Approval, Launches In Australia
Sydney, NSW (17 Nov, 2022) – The HA TECH SARS-CoV-2 Rapid Antigen Test Kit launches in Australia. The kit has been approved by TGA and ...
18
Oct
HA TECH wins the NSW Development Impact Award at the 2022 Premier’s NSW Export Awards
HA Tech wins the NSW Development Impact Award at the 2022 Premier’s NSW Export Awards!
The 2022 NSW Premier’s Export Awards ceremony...
10
Oct
HA TECH Is A Finalist Of The 2022 Premier’s NSW Export Awards For The Second Consecutive Year
Sydney, NSW (10 Oct, 2022) –
Yet again, HA TECH becomes a finalist of the 2022 Premier’s NSW Export Awards in the “NSW Development I...
09
Nov
HA TECH receives an award from MED TECH outlook for being a top in vitro diagnostic solution provider in APAC 2021.
Sydney, NSW (05 NOV, 2021) – HA TECH receives an award from MED TECH outlook for being a top in vitro diagnostic solution provider in ...
09
Nov
HA TECH is a finalist of the 2021 Premier’s NSW Export Awards in two categories.
Sydney, NSW (28 Sep, 2021) – HA TECH became a finalist of the 2021 Premier’s NSW Export Awards in two categories.
In a World that ne...
11
Dec
COVID-19 Kit Receives TGA Approval, Launches In Australia
Sydney, NSW (11 Dec, 2020) – HA TECH announced today the product launch of the SARS-CoV-2 RT-PCR Multiplex Diagnostic Kit. The kit has ...
24
Oct
CE Marking Received
Sydney, NSW (October 24, 2020) – HA TECH announced today the CE mark of its SARS-CoV-2 RT-PCR Multiplex Diagnostic Kit, clearing the wa...
25
Aug
Land acquisition for large scale API manufacturing
Sydney, NSW. (25 Aug 2020)– HA TECH announced the signing of a land lease agreement with the Bangladesh Economic Zones Authority (BEZ...